← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

Chair and CEO Martine A Rothblatt sold $4.6M of United Therapeutics Corporation

Sold$4,631,619
$487.54Price
9,500Shares
−3%Stake

What UTHR did after the filing

Filed Sep 4Copier in Sep 8
The stock from Tue, Sep 8 open, $494.74
+9.8%
S&P 500, same days
−0.3%

29 of 30 trading days so far, to the Oct 19 close.

Traded Thu, Sep 3. Filed Fri, Sep 4, 4:31 PM ET, after the close. Returns use the Sep 8 open and the Oct 19 close. Not investment advice.